Kirk Malloy

Dr. Malloy has held management and executive leadership positions in rapidly growing life science and diagnostics companies for over 20 years. He founded BioAdvisors in April 2016 which provides strategic consulting services to life science, diagnostics and genomics companies. He also currently serves as Lead Independent Director for Organovo (ONVO); corporate director for Nanostring Technologies (NSTG); Executive Chairman for Agilome; and as a member of the board of directors for Edico Genome, iGenomX and JumpCode Genomics. For the previous 13 years, he was Senior Vice President and General Manager of Life Sciences and Applied Markets at Illumina, a leading developer and supplier of genetic analysis instrumentation, assays and software for the life science and diagnostics markets. In this role he ran the company’s largest business unit with a P&L of over $1B and was responsible for the company's core platform technologies. His business unit served the life sciences and applied markets (Agrigenomics, Micriobiology, Transplant Biology, Forensics, Complex Diseases and Healthy Clinical Genomes). He joined Illumina in 2002 and previously managed a team of 450 in 50 countries as Vice President of Global Customer Solutions and Vice President of Quality, building and leading the commercial support and training organization and a professional service business generating more than $150M in annual revenues. Dr. Malloy earned his B.S. in Biology from the University of Miami, and his M.S. and Ph.D. from the University of Delaware and held post-doctoral and instructor positions at Boston University and Northeastern University. He completed a certification for Corporate Directors at UCLA’s Anderson School in 2012. He also serves on the Board of Trustees for the Pacific Ridge School, and is on the Dean’s Advisory Board for the University of Delaware. He has 12 peer-reviewed publications and book chapters, dozens of invited and contributed scientific presentations and has been a reviewer for various scientific journals.

Verogen